ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

NCT05082259 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Cervical Cancer
Triple Negative Breast Cancer

Interventions

DRUG: ASTX660
DRUG: Pembrolizumab

Sponsor

Institute of Cancer Research, United Kingdom

Collaborators

[object Object]
[object Object]
[object Object]